Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Armoiry

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 4, 2022
Cost-effectiveness of the MitraClip device in secondary mitral regurgitation: comment upon the article by Estler et alMartin Connock, Xavier Armoiry
Heart (British Cardiac Society)|May 9, 2022
Correspondence on 'Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation does need confirmation' by Cohen <i>et al</i>Xavier Armoiry, Martin Connock
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 1, 2020
A comparison of published time invariant Markov models with Partitioned Survival models for cost effectiveness estimation; three case studies of treatments for glioblastoma multiformeMartin Connock, Peter Auguste, Xavier Armoiry
The Journal of Thoracic and Cardiovascular Surgery|November 20, 2018
Innovative valve disease therapies, a potential benefit for patients but calling for more clinical evaluationXavier Armoiry, Jean-François Obadia, Antoine Duclos
Health Policy (Amsterdam, Netherlands)|August 18, 2024
Early access programs for medical devices in France: Overview of recent reforms and outcomes (2015-2022)Tess Martin, Alexandra Hervias, Xavier Armoiry, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|November 18, 2021
Effectiveness of Non-Pharmacological Interventions for Irritable Bowel Syndrome: A Systematic ReviewFlorent Amsallem, Stéphane Sanchez, Xavier Armoiry, et al.
BMJ Open|December 11, 2024
Cost-effectiveness of percutaneous mitral repair for patients with severe secondary mitral regurgitation: an updated evaluation using a modelling approach based on COAPT final data after 5-year follow-upMartin Connock, Peter Auguste, Jean-François Obadia, et al.
Plos One|November 9, 2020
Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitationXavier Armoiry, Jean-François Obadia, Peter Auguste, et al.
Journal of Neuro-Oncology|May 26, 2019
Cost-effectiveness of tumor-treating fields added to maintenance temozolomide in patients with glioblastoma: an updated evaluation using a partitioned survival modelMartin Connock, Peter Auguste, Claude Dussart, et al.
Advances and Technical Standards in Neurosurgery|October 29, 2015
5-Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Surgery of High-Grade Gliomas: A Systematic ReviewJacques Guyotat, Johan Pallud, Xavier Armoiry, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 4, 2022
Cost-effectiveness of the MitraClip device in secondary mitral regurgitation: comment upon the article by Estler et alMartin Connock, Xavier Armoiry
Heart (British Cardiac Society)|May 9, 2022
Correspondence on 'Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation does need confirmation' by Cohen <i>et al</i>Xavier Armoiry, Martin Connock
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 1, 2020
A comparison of published time invariant Markov models with Partitioned Survival models for cost effectiveness estimation; three case studies of treatments for glioblastoma multiformeMartin Connock, Peter Auguste, Xavier Armoiry
The Journal of Thoracic and Cardiovascular Surgery|November 20, 2018
Innovative valve disease therapies, a potential benefit for patients but calling for more clinical evaluationXavier Armoiry, Jean-François Obadia, Antoine Duclos
Health Policy (Amsterdam, Netherlands)|August 18, 2024
Early access programs for medical devices in France: Overview of recent reforms and outcomes (2015-2022)Tess Martin, Alexandra Hervias, Xavier Armoiry, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|November 18, 2021
Effectiveness of Non-Pharmacological Interventions for Irritable Bowel Syndrome: A Systematic ReviewFlorent Amsallem, Stéphane Sanchez, Xavier Armoiry, et al.
BMJ Open|December 11, 2024
Cost-effectiveness of percutaneous mitral repair for patients with severe secondary mitral regurgitation: an updated evaluation using a modelling approach based on COAPT final data after 5-year follow-upMartin Connock, Peter Auguste, Jean-François Obadia, et al.
Plos One|November 9, 2020
Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitationXavier Armoiry, Jean-François Obadia, Peter Auguste, et al.
Journal of Neuro-Oncology|May 26, 2019
Cost-effectiveness of tumor-treating fields added to maintenance temozolomide in patients with glioblastoma: an updated evaluation using a partitioned survival modelMartin Connock, Peter Auguste, Claude Dussart, et al.
Advances and Technical Standards in Neurosurgery|October 29, 2015
5-Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Surgery of High-Grade Gliomas: A Systematic ReviewJacques Guyotat, Johan Pallud, Xavier Armoiry, et al.
Pageof 9